{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:28:54Z","timestamp":1769243334704,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.atherosclerosis.2017.06.353","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T17:38:06Z","timestamp":1498066686000},"page":"219-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["The inverse association of HDL-cholesterol with future risk of hypertension is not modified by its antioxidant constituent, paraoxonase-1: The PREVEND prospective cohort study"],"prefix":"10.1016","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2625-0273","authenticated-orcid":false,"given":"Setor K.","family":"Kunutsor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8028-6488","authenticated-orcid":false,"given":"Lyanne M.","family":"Kieneker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan J.L.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin P.F.","family":"Dullaart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib1","doi-asserted-by":"crossref","first-page":"NP1","DOI":"10.1177\/2047487316653709","volume":"23","author":"Authors\/Task Force","year":"2016","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"Suppl 2","key":"10.1016\/j.atherosclerosis.2017.06.353_bib2","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/01.hjr.0000277984.31558.c4","volume":"14","author":"Graham","year":"2007","journal-title":"Eur. J. Cardiovasc Prev. Rehabil."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score","volume":"297","author":"Ridker","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib5","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Prospective Studies","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.HYP.0000196306.42418.0e","article-title":"Dyslipidemia and the risk of incident hypertension in men","volume":"47","author":"Halperin","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib7","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/eurheartj\/ehn061","article-title":"Dyslipidaemia as a predictor of hypertension in middle-aged men","volume":"29","author":"Laaksonen","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib8","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1001\/archinte.165.20.2420","article-title":"A\u00a0prospective study of plasma lipid levels and hypertension in women","volume":"165","author":"Sesso","year":"2005","journal-title":"Arch. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/jhh.2011.70","article-title":"Triglycerides and triglycerides to high-density lipoprotein cholesterol ratio are strong predictors of incident hypertension in Middle Eastern women","volume":"26","author":"Tohidi","year":"2012","journal-title":"J.\u00a0Hum. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.STR.0000116869.64771.5A","article-title":"Blood pressure and stroke: an overview of published reviews","volume":"35","author":"Lawes","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib11","first-page":"e6","article-title":"Heart disease and stroke statistics\u20132013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM199602083340607","article-title":"Hypertension and associated metabolic abnormalities\u2013the role of insulin resistance and the sympathoadrenal system","volume":"334","author":"Reaven","year":"1996","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"Suppl 2","key":"10.1016\/j.atherosclerosis.2017.06.353_bib13","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.2337\/dc08-s245","article-title":"Possible role of oxidative stress in the pathogenesis of hypertension","volume":"31","author":"Ceriello","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/hr.2010.264","article-title":"The role of oxidative stress in the pathophysiology of hypertension","volume":"34","author":"Rodrigo","year":"2011","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/HYPERTENSIONAHA.110.163576","article-title":"Inflammation, immunity, and hypertension","volume":"57","author":"Harrison","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib16","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1440-1681.2010.05387.x","article-title":"Anti-atherogenic effects of high-density lipoprotein on nitric oxide synthesis in the endothelium","volume":"37","author":"Andrews","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib17","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2174\/138161210791051022","article-title":"High-density lipoprotein: key molecule in cholesterol efflux and the prevention of atherosclerosis","volume":"16","author":"Meurs","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1440-1681.2010.05380.x","article-title":"Anti-oxidant properties of high-density lipoprotein and atherosclerosis","volume":"37","author":"Podrez","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/pr.58.3.1","article-title":"Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis","volume":"58","author":"Kontush","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.atherosclerosis.2015.12.021","article-title":"Serum paraoxonase-1 activity and risk of incident cardiovascular disease: the PREVEND study and meta-analysis of prospective population studies","volume":"245","author":"Kunutsor","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00041552-199809000-00008","article-title":"Antioxidants for hypertension","volume":"7","author":"Kitiyakara","year":"1998","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbagen.2005.07.005","article-title":"Oxidative inactivation of paraoxonase\u2013implications in diabetes mellitus and atherosclerosis","volume":"1725","author":"Karabina","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2362.2011.02604.x","article-title":"Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL","volume":"42","author":"Kappelle","year":"2012","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2012.01.047","article-title":"Paraoxonase1 deficiency in mice is associated with hypotension and increased levels of 5,6-epoxyeicosatrienoic acid","volume":"222","author":"Gamliel-Lazarovich","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib25","doi-asserted-by":"crossref","first-page":"e786","DOI":"10.1097\/MD.0000000000000786","article-title":"Paraoxonase and arylesterase activities in dipper and non-dipper prehypertensive subjects","volume":"94","author":"Yuksel","year":"2015","journal-title":"Med. Baltim."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/10641963.2016.1200602","article-title":"High morning blood pressure surge is associated with oxidative stress and paraoxonase 1 activity in newly diagnosed hypertensive patients","volume":"38","author":"Kaypakli","year":"2016","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/10641963.2016.1174255","article-title":"Association of paraoxonase 1 (PON1) gene polymorphisms and concentration with essential hypertension","volume":"38","author":"Turgut Cosan","year":"2016","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib28","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/01.hjh.0000234109.46486.9b","article-title":"The PON1192RR genotype is associated with a higher prevalence of arterial hypertension","volume":"24","author":"Marra","year":"2006","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib30","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1001\/jama.2009.565","article-title":"Microalbuminuria and risk of venous thromboembolism","volume":"301","author":"Mahmoodi","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib31","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/aje\/kwn209","article-title":"Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality","volume":"168","author":"Lambers Heerspink","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib32","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3945\/ajcn.112.054114","article-title":"Urinary and plasma magnesium and risk of ischemic heart disease","volume":"97","author":"Joosten","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2008.11.001","article-title":"Paraoxonase 1 (PON1) status and substrate hydrolysis","volume":"235","author":"Richter","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1194\/jlr.M400052-JLR200","article-title":"Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia","volume":"46","author":"van Himbergen","year":"2005","journal-title":"J.\u00a0lipid Res."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib35","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehm062","article-title":"High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides","volume":"28","author":"Borggreve","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.atherosclerosis.2009.07.042","article-title":"High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol","volume":"208","author":"Dullaart","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib37","doi-asserted-by":"crossref","first-page":"e39110","DOI":"10.1371\/journal.pone.0039110","article-title":"Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein","volume":"7","author":"Corsetti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.atherosclerosis.2015.09.006","article-title":"Inverse linear associations between liver aminotransferases and incident cardiovascular disease risk: the PREVEND study","volume":"243","author":"Kunutsor","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib39","doi-asserted-by":"crossref","first-page":"e0132822","DOI":"10.1371\/journal.pone.0132822","article-title":"Serum alkaline phosphatase and risk of incident cardiovascular disease: interrelationship with high sensitivity C-Reactive protein","volume":"10","author":"Kunutsor","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib42","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","author":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection","year":"2001","journal-title":"Jama"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib43","series-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015","volume":"317","author":"Forouzanfar","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib45","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","article-title":"Collaborators, GBDRF, Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib46","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-139-9-200311040-00011","article-title":"Pathogenesis of hypertension","volume":"139","author":"Oparil","year":"2003","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.95.1.5","article-title":"Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease","volume":"95","author":"Selwyn","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.atherosclerosis.2004.04.023","article-title":"Correlates of carotid artery stiffness in young adults: the Bogalusa Heart Study","volume":"176","author":"Urbina","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib49","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1161\/01.CIR.0000154555.07002.CA","article-title":"Cardiology patient page. The \u201cgood cholesterol\u201d: high-density lipoprotein","volume":"111","author":"Toth","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib50","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/hc3901.096667","article-title":"High-density lipoproteins and endothelial function","volume":"104","author":"O'Connell","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/HCO.0b013e3283043806","article-title":"Multiple actions of high-density lipoprotein","volume":"23","author":"Florentin","year":"2008","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib52","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1432-1033.1993.tb17620.x","article-title":"Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase","volume":"211","author":"Blatter","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib53","first-page":"675","article-title":"The separation of sheep and human serum \u201cA\u201d-esterase activity into the lipoprotein fraction by ultracentrifugation, Comparative biochemistry and physiology. B","volume":"82","author":"Mackness","year":"1985","journal-title":"Comp. Biochem."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.atherosclerosis.2013.06.019","article-title":"The positive relationship of serum paraoxonase-1 activity with apolipoprotein E is abrogated in metabolic syndrome","volume":"230","author":"Dullaart","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.metabol.2017.05.004","article-title":"Incident type 2 diabetes is associated with HDL, but not with its anti-oxidant constituent - paraoxonase-1: the prospective cohort PREVEND study","volume":"73","author":"Kunutsor","year":"2017","journal-title":"Metab. - Clin. Exp."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib56","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/ATVBAHA.109.186031","article-title":"Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function","volume":"29","author":"Davidson","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.06.353_bib57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cca.2008.12.019","article-title":"Validation of PON1 enzyme activity assays for longitudinal studies","volume":"402","author":"Huen","year":"2009","journal-title":"Clin. Chim. Acta"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017306020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017306020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:38:37Z","timestamp":1758155917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017306020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":57,"alternative-id":["S0021915017306020"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.06.353","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The inverse association of HDL-cholesterol with future risk of hypertension is not modified by its antioxidant constituent, paraoxonase-1: The PREVEND prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.06.353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}